echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > The 2021 financial report of multinational pharmaceutical companies is released. Who will be the TOP10?

    The 2021 financial report of multinational pharmaceutical companies is released. Who will be the TOP10?

    • Last Update: 2022-03-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, a number of MNCs (multinational corporations) have intensively released their 2021 financial reports.


    During the sorting process, we focused on four indicators, namely: total revenue, R&D investment, revenue in China, and revenue from the top three blockbuster drugs


    1.


    1.


    *The market value statistics time is Sunday, February 13, 2022

    Among them, Johnson & Johnson holds the top spot in MNC with an annual revenue of $93.


    From the perspective of growth rate, Pfizer will be the well-deserved big winner in 2021.


    2.


    2.


    Sales in emerging markets grew by 89% year-on-year


    Although AstraZeneca's sales growth in China is not high, only 4%, but among the six MNCs that have announced revenue in China, AstraZeneca China has the highest sales revenue


    The highest sales revenue in China

    3.


    3.


    5 companies account for more than 20% of R&D;

    Blockbuster drugs are the current source of growth for companies, and the growth rate of blockbuster drug sales to a certain extent is expected to contribute to the drug's performance in the next year


    Pfizer's Comirnaty Pfizer's Comirnaty AbbVie's Humira AbbVie's Humira

    The strong are Hengqiang.


    The growth rate is over 40% The growth rate is over 40%

    4.


    4.


    New diseases without means of prevention, and new markets for therapeutic drugs
    .
    emerging markets along the “Belt and Road”,
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.